Ranbaxy Board Approves Separate Research Unit, Plans Share Listing This Year
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Ranbaxy Laboratories' board Feb. 19 approved setting up a research unit called Ranbaxy Life Science Research Ltd., the latest foray by Indian generic pharma firms to create dedicated research and development arms to cut expenses on the parent balance sheet and attract new contract business
You may also be interested in...
Ranbaxy To Announce New Drug Development Tie-Up In May
NEW DELHI - India's top generic drug firm Ranbaxy Laboratories expects to announce a new tie up with a large multinational drug firm in May to develop new chemical entities at its recently spun-off Life Science Research unit similar to a current deal with GlaxoSmithKline inked in 2003 and expanded last year, the company's chief executive said
Ranbaxy To Announce New Drug Development Tie-Up In May
NEW DELHI - India's top generic drug firm Ranbaxy Laboratories expects to announce a new tie up with a large multinational drug firm in May to develop new chemical entities at its recently spun-off Life Science Research unit similar to a current deal with GlaxoSmithKline inked in 2003 and expanded last year, the company's chief executive said
Booming Clinical Research Business Could Trigger Regulatory Overhaul In India
SAN FRANCISCO - Foreign companies could soon get the go-ahead to conduct Phase I studies in India, as part of a national regulatory overhaul spurred on by booming clinical research business, regional experts say